You are here

Profound Medical to Participate in the 2019 BTIG MedTech, Life Science & Diagnostic Tools Conference

TORONTO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that combines real-time Magnetic Resonance (“MR”) imaging and ultrasound technology for the precise, incision-free ablation of diseased tissue, today announced that members of its management team are scheduled to participate in the BTIG MedTech, Life Science & Diagnostic Tools Conference on Wednesday, February 27, 2019 in Snowbird, Utah.
Wednesday, February 20, 2019 - 16:30